Education
About Us
Working with TipRanks
Follow Us
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 566.00K | $ 392.00K | $ 1.50M | $ 208.38M | $ 12.62M |
| Gross Profit | $ 566.00K | $ 392.00K | $ 1.50M | $ 208.38M | $ 12.62M |
| Operating Income | $ -61.88M | $ -59.28M | $ -55.55M | $ 124.21M | $ -81.43M |
| EBITDA | $ -57.77M | $ -57.01M | $ -54.17M | $ 124.45M | $ -81.12M |
| Net Income | $ -26.43M | $ -52.34M | $ -54.17M | $ 122.83M | $ -81.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 53.08M | $ 105.83M | $ 129.00M | $ 187.80M | $ 72.03M |
| Total Assets | $ 92.17M | $ 144.03M | $ 155.27M | $ 194.54M | $ 75.93M |
| Total Debt | $ 14.76M | $ 16.00M | $ 16.54M | $ 0.00 | $ 0.00 |
| Net Debt | $ -11.55M | $ -11.04M | $ -28.33M | $ -187.80M | $ -72.03M |
| Total Liabilities | $ 23.94M | $ 56.23M | $ 22.99M | $ 14.80M | $ 32.29M |
| Stockholders' Equity | $ 68.23M | $ 87.80M | $ 132.27M | $ 179.75M | $ 43.63M |
| Cash Flow | |||||
| Free Cash Flow | $ -56.03M | $ -45.92M | $ -56.65M | $ 118.43M | $ -51.97M |
| Operating Cash Flow | $ -55.96M | $ -45.78M | $ -55.23M | $ 118.61M | $ -51.58M |
| Investing Cash Flow | $ 54.59M | $ -2.58M | $ -87.88M | $ -1.82M | $ 34.65M |
| Financing Cash Flow | $ 622.00K | $ 30.54M | $ 180.66K | $ 904.08K | $ 47.07M |